Hepatitis delta is the most severe form of chronic viral hepatitis.
Pegylated interferon alpha is currently the only recommended treatment option.
PEG-IFNa therapy leads to a virological response in about 25–30% of patients.
A beneficial clinical long-term outcome of IFNa-based therapy has been suggested.
New treatment strategies are in clinical development.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址:北京市海淀区学院路29号 邮编:100083 电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700 |